New bladder cancer treatment tested before surgery
NCT ID NCT05055050
Summary
This early-stage study is testing the safety of an experimental drug called UGN-201 in bladder cancer patients who are scheduled to have their bladder surgically removed. The research involves 10 participants and aims to understand if UGN-201 is safe to give before surgery and whether it might help shrink tumors. Researchers will also look for biological changes in blood, urine, and tumor tissue to learn how the treatment works.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.